Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Universe Pharmaceuticals ( (UPC) ) has provided an announcement.
On March 8, 2025, Universe Pharmaceuticals INC held an extraordinary general meeting of shareholders, initially scheduled for March 1, 2025, to address two key proposals. Despite a low turnout, the meeting proceeded under the company’s articles of association, and both proposals were approved. The first proposal involved consolidating the company’s shares, reducing the number of shares by combining every 50 shares into one, subject to the board’s discretion. The second proposal was to adopt a new memorandum of association reflecting this share consolidation. These changes are expected to streamline the company’s share structure, potentially impacting its market operations and shareholder value.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC operates in the pharmaceutical industry, focusing on the development and distribution of traditional Chinese medicine products. The company is based in Ji’an, Jiangxi, China, and is involved in the production of a wide range of medicinal products aimed at various health conditions.
YTD Price Performance: -79.38%
Average Trading Volume: 12,517,964
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.14M
For detailed information about UPC stock, go to TipRanks’ Stock Analysis page.